Supercharging the Next Era of Immunotherapies
The Immunotherapy stream at PEGS brings together the boldest innovations shaping the next era of immunotherapies for cancer, autoimmune disease, and beyond. Across three dynamic tracks, the program showcases breakthroughs in T-cell and immune-cell engagers, immune engineering, microbiome, cellular therapies, and in vivo reprogramming powered by RNA, viral vectors, and AI. Part 1: T-Cell Engagers spotlights the next wave of immune cell engagers designed for greater safety, efficacy, and precision. Part 2: Advances in Immunotherapy dives into strategies to overcome resistance and persistence, engineer safer, smarter cell therapies, and unlock new opportunities in solid tumors and autoimmune conditions. Part 3: Next-Generation Immunotherapies looks to the rapid rise of in vivo immune cell reprogramming, new targets, oncolytic viruses, nanomedicine, and AI/ML-guided discovery of novel targets, including the dark genome. Don’t miss out on the latest technologies and science driving the next era of immunotherapies.
Conferences Include:
May 11-12
Emerging T Cell Engagers
May 12-13
Advances in Immunotherapy
May 14-15
Next-Generation Immunotherapies